Caliway Biopharmaceuticals (CLBPF) Q4 2025 Earnings

7NovConfirmed
Q3 2025
Q4 2025
-0.01
-0
-0
-0

Details

Expected EPS
-0.00623029
Actual EPS
-0.00016297127
Surprise EPS
0.01
Surprise Percent
+97.38%

Description

Caliway Biopharmaceuticals (CLBPF) has reported earnings of -0.00016297127 per share for Q4 2025.

0 Comments

Share your thoughts